Europe PDX models Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Published Report
  • Jul 2020
  • Europe
  • 118 Pages
  • No of Tables: 22
  • No of Figures: 63

Europe PDX Models Market, By Type (Mice Models and Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Lung Tumor Models, Urological Tumor Models, Hematological Tumor Models and Others), Application (Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research and Biomarker Analysis), Technique (Heterotopic Implantation and Orthotropic Implantation), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Organizations and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe) Industry Trends & Forecast to 2027

Europe PDX models MarketMarket Analysis and Insights  : Europe PDX models Market

PDX models market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.0% in the forecast period of 2020 to 2027 and is expected to reach USD 99,901.36 thousand by 2027 from USD 30,359.09 thousand in 2019. Rising demand of humanized PDX models, increasing demand for personalized medicine in PDX models are the major drivers which has propelled the demand of the market in the forecast period.

In patient derived xenografts models (PDX) models the cancerous tumor or cells from the patients are transferred/ implanted into the immunodeficient rodents like mice or rat. PDX models are developed for the cancer research on the basis of expectations that these models have the capability to retain the tumor characteristics particularly for the patient derived orthotropic xenograft. Basically these models include the uninterrupted transfer of human disease sample into the mice.

PDX models are considered as an effective tool in the field of biomedical research, preclinical trials as both the species have similarities and these models have the capability of carrying the characteristics of the tumor, and also allow studying the tumor and its heterogeneity. They help in the evaluation of the tumor growth rate, life cycle of the tumor and growth rate of the tumor in different conditions. They also help in differentiating between the adult and childhood cancer. The adoption of the new therapies, patient specific therapies, and personalized medicine are all established by the use of PDX models in the basic cancer research and rug development.  

The PDX models market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Europe PDX models MarketEurope PDX models Market Scope and Market Size

PDX models market is segmented on the basis of type, tumor type, application, technique and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the PDX models market is segmented into mice models and rat models. In 2020, mice models segment is expected to dominate the market as researchers are increasingly using mice models more often than rats, because of mice superiority as genetic models. Further, smaller size of mice does offer some advantages, including requiring lower drug dosages, which makes them more cost-effective in drug development research.
  • On the basis of tumor type, the PDX models market is segmented gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, lung tumor models, urological tumor models, hematological tumor models and others. In 2020, gastrointestinal tumor models segment is expected to dominate the market as due to increasing number of gastrointestinal tumor models along with increasing gastrointestinal tumor researches in academic & research institutions and contract research organizations.
  • On the basis of application, the PDX models market is segmented into preclinical drug development, precision medicine, co-clinical trials, basic cancer research and biomarker analysis. In 2020, basic cancer research segment is expected to dominate the market due to increasing adoption of PDX Models for basic cancer research.  Basic cancer research is the characterization of cancer biology and to explore mechanisms which is involved for prediction or understanding of cancer. PDX models essentially provide importance in vivo and ex vivo evidence to aid basic studies of cancer, including tumor characterization, tumorigenesis, and metastasis.
  • On the basis of technique, the PDX models market is segmented into heterotopic implantation and orthotropic implantation. In 2020, heterotopic implantation segment is expected to dominate the market as heterotopic implantation offers various advantages including easy methods of cell implantation, accurate monitoring of tumor size. Subcutaneous and intravenous PDX models, for solid tumors and leukemia, respectively, are most widely used in cancer research. Moreover, heterotopic implantation is less technically challenging and time-consuming as compared to orthotropic implantation.
  • On the basis of end user, the PDX models market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic and research organizations and others. In 2020, academic & research organizations segment is expected to dominate the market as the PDX models usage are continuously increasing in academic & research institutions for basic cancer research particularly for characterization of cancer biology, tumorigenesis and metastasis.

PDX models Market Country Level Analysis

The PDX models market is analysed and market size information is provided by type, tumor type, application, technique and end user.

The countries covered in the PDX models market report are the Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and Rest of Europe.   

Germany is dominating the European market with the increasing environmental concerns by environmental agencies on the water quality such as the water framework directive in europe.

The country section of the PDX models market also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the PDX models market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Increase in R&D Activities in the Pharmaceutical Industries

PDX models market also provides you with detailed market analysis for every country growth in aesthetic industry with PDX models sales, impact of advancement in the PDX models and changes in regulatory scenarios with their support for the PDX models market. The data is available for historic period 2010 to 2018.  

Competitive Landscape and PDX Models Market Share Analysis

PDX models market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to PDX models market.

The major players covered in the report are Crown Bioscience, Champions Oncology, Inc., Charles River Laboratories, Wuxi AppTec, Onco Design, Covance Inc., EPO Berlin-Buch Gmbh, EUROPDX, Explora Biolabs, Horizon Discovery Ltd., Urosphere SAS, Xentech and Xenopat, among others domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the PDX models market.

For instance,

  • In October 2019, Crown Bioscience Inc. announced strategic collaboration with NEXT Oncology for focusing more on preclinical drug development by providing new relevant models. This collaboration has helped the company to serve more customers as they have the global presence worldwide and could generate more revenue.
  • In April 2018, Jackson Laboratory and European Bioinformatics Institute created first cancer research portal for PDX models. By using these models researchers can understand better a drug reaction on the patient which is patient specific too. This has provided wide variety of the models at one place quickly.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the PDX models market which also provides the benefit for organisation to improve their offering for PDX models.

Customization Available: Europe PDX models Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES EUROPE PDX MODELS MARKET

TABLE 1 EUROPE PDX MODELS MARKET, BY TYPE, 2016– 2025, (USD MILLION)

TABLE 2 EUROPE MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 3 EUROPE RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 4 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016– 2025 (USD MILLION)

TABLE 5 EUROPE GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 6 EUROPE GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 7 EUROPE RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 8 EUROPE UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 9 EUROPE HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 10 EUROPE OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 11 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016– 2025 (USD MILLION)

TABLE 12 EUROPE PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 13 EUROPE BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 14 EUROPE PDX MODELS MARKET, BY END USER, 2016– 2025, (USD MILLION)

TABLE 15 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 16 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 17 EUROPE ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 18 EUROPE PDX MODELS MARKET, BY COUNTRY , 2016 – 2025 (USD MILLION)

TABLE 19 EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 20 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 21 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 22 EUROPE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 23 GERMANY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 24 GERMANY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 25 GERMANY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 26 GERMANY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 27 FRANCE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 28 FRANCE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 29 FRANCE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 30 FRANCE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 31 U.K. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 32 U.K. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 33 U.K. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 34 U.K. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 35 ITALY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 36 ITALY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 37 ITALY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 38 ITALY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 39 SPAIN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 40 SPAIN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 41 SPAIN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 42 SPAIN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 43 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 44 SWITZERLAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 45 SWITZERLAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 46 SWITZERLAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 47 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 48 NETHERLANDS PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 49 NETHERLANDS PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 50 NETHERLANDS PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 51 TURKEY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 52 TURKEY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 53 TURKEY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 54 TURKEY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 55 BELGIUM PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 56 BELGIUM PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 57 BELGIUM PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 58 BELGIUM PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 59 RUSSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 60 RUSSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 61 RUSSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 62 RUSSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 63 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions